Clin2
NCT07729462Possibly a fitRecruiting

Rimegepant for preventing chronic migraine

Preventive Treatment of Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had chronic migraine (15 or more headache days per month) for at least 1 year.
  • Your migraine started before age 50 and became chronic before age 65.
  • Your migraine attacks last between 4 and 72 hours if untreated.
  • You have not used rimegepant for migraine prevention before.
  • You have not failed more than 4 prior preventive medications, including at least 2 different types.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06641466Recruiting· Phase 3
Study of Rimegepant for preventing menstrual migraine in women

This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.

Phoenix, Arizona
NCT04743141Recruiting· Phase 3
Long-term migraine medicine study for kids with migraine attacks

This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.

Scottsdale, Arizona
NCT06401642Recruiting· Phase 4
Zavegepant for acute migraine with CGRP preventives

This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.

Phoenix, Arizona
NCT06728345Not yet recruiting
Rimegepant for preventing migraines in women

This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.

NCT06409832Recruiting
Study of rimegepant for migraine prevention

This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.

Florence, Florence
NCT07301008Recruiting· Phase 4
Rimegepant to prevent predictable trigger-induced migraines

This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.

McLean, Virginia

Hear when a new Preventive Treatment of Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.